Increasing Chronic Disease across the globe further boosting the growth of the Global Renal Replacement Therapy Market

Published: Jul 2021

The global renal replacement therapy market is anticipated to grow at a considerable CAGR of around 7.3% during the forecast period (2021-2027). One of the major factors that drive the market growth includes increasing chronic diseases across the globe. For instance, the two main reasons for kidney disease are patients with diabetes and high blood pressure. These two diseases were the primary diagnosis in 76% of kidney failure cases, and the remaining 29% of patients having hypertension. Diabetes and high blood pressure responsible for up to two-thirds of kidney disease cases, Diabetes occurs when a person’s blood sugar is too high that causes damage to the kidney and several organs of the patient’s body including the heart, and eyes. According to the national kidney foundation, kidney disease causes more mortality rate than prostate cancer or breast cancer. Kidney disease affects around 37 million people in the US in 2021. The total number of patients having kidney failure will likely surpass 1 million by 2030. While about 100,000 Americans are waiting for a kidney transplant, and only 22,817 Americans received one in 2020. About one-third of these transplants came from living donors.

Browse the full report description of "Global Renal Replacement Therapy Market Size, Share & Trends Analysis Report By Therapy Type (Dialysis, Hemodialysis, Peritoneal Dialysis), By End-User (Hospitals and Clinics, Research Institutes) Forecast, 2021-2027" at https://www.omrglobal.com/industry-reports/renal-replacement-therapy-market

Renal replacement therapy replaces nonendocrine kidney function in patients having renal failure. The therapy is recommended when the kidneys are not functioning properly or are eternally damaged. The most possible treatment in renal replacement therapy includes peritoneal dialysis, hemofiltration, hemodialysis, and intermittent hemodialysis. All modalities exchange solute and remove fluid from the blood, using dialysis and purification across permeable membranes. The major driver of the growth of the renal replacement therapy market includes the prevalence of kidney diseases, rising chronic disease, increasing diabetic population, changes in lifestyle such as the problem with kidney is mostly seen in person with smoking habits. COVID-19 is targeting people having kidney disease, kidney transplant patients, and those at risk for kidney disease.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Therapy type

o ByEnd-user 

  • Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

  • Competitive Landscape – Fresenius Medical Care AG & Co., Medica S.p.A., Medtronic, cytosorbents, Baxter.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Renal Replacement Therapy Market 

By Therapy Type

  • Dialysis
  • Hemodialysis
  • Peritoneal Dialysis

By End-User 

  • Hospitals and Clinics
  • Research Institutes

Global Renal Replacement Therapy Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World

  • Latin America 
  • Middle East & Africa

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/renal-replacement-therapy-market